Quality system inspection meeting
This article was originally published in The Gray Sheet
Executive SummaryFDA's quality system inspection strategy slated for public discussion June 18 in Rockville, Maryland. The agency expects to release a guidance outlining the strategy within the next few weeks and has placed limited information at the web site for the upcoming draft guidance (www.fda.gov/cdrh/gmp/gmp.html)
You may also be interested in...
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.